SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tomato who wrote (504)8/1/2002 1:40:35 PM
From: scaram(o)uche  Read Replies (2) of 724
 
Shareholder's equity up 2.4M, quarter to quarter, 3.4M, year to date, to $29.7M.

Just looking at the report, first blush. $0.11/share profit, lower than I expected. Accounts payable and accrued expenses down 2.2M. Cash up 2.1M.

First-half 2002 revenues of $29.4 million were relatively flat compared with $29.5 million last year. Adjusted to exclude fully custom-engineered bioprocess equipment and DGI revenues aggregating $4.1 million in last year's first half, net sales increased 16 percent for the 2002 six-months.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News